Cargando…

Trajectory of clinical symptoms in relation to amyloid chronicity

INTRODUCTION: While it is generally appreciated that amyloid precedes symptomatic Alzheimer's disease (AD) by decades, a greater understanding of this timeline may increase prognostic accuracy, planning, and care of persons who are on the AD continuum. METHODS: We examined trajectories of Clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Birdsill, Alex C., Koscik, Rebecca L., Cody, Karly A., Jonaitis, Erin M., Cadman, Robert V., Erickson, Claire M., Chin, Nathaniel A., Przybelski, Robert J., Carlsson, Cynthia M., Asthana, Sanjay, Christian, Bradley T., Eisenmenger, Laura B., Betthauser, Tobey J., Johnson, Sterling C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Disease Heterogeneity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489232/ https://www.ncbi.nlm.nih.gov/pubmed/36187195 http://dx.doi.org/10.1002/dad2.12360

Ejemplares similares

Associations of the Lifestyle for Brain Health index with longitudinal cognition and brain amyloid beta in clinically unimpaired older adults: Findings from the Wisconsin Registry for Alzheimer's Prevention
por: Cody, Karly A., et al.
Publicado: (2022)

Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers
por: Rivera‐Rivera, Leonardo A., et al.
Publicado: (2021)

Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
por: Betthauser, Tobey J, et al.
Publicado: (2020)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome
por: Krinsky‐McHale, Sharon J., et al.
Publicado: (2022)

Amyloid beta associations with connected speech in cognitively unimpaired adults
por: Mueller, Kimberly D., et al.
Publicado: (2021)

Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts
por: Betthauser, Tobey J, et al.
Publicado: (2022)

rasterdiv—An Information Theory tailored R package for measuring ecosystem heterogeneity from space: To the origin and back
por: Rocchini, Duccio, et al.
Publicado: (2021)

The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults
por: Ennis, Gilda E., et al.
Publicado: (2023)

Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease
por: Langhough Koscik, Rebecca, et al.
Publicado: (2021)

Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer’s Prevention
por: Du, Lianlian, et al.
Publicado: (2023)

Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
por: Erickson, Pontus, et al.
Publicado: (2023)

Prescription Medications and Co-Morbidities in Late Middle-Age are Associated with Greater Cognitive Declines: Results from WRAP
por: Du, Lianlian, et al.
Publicado: (2022)

Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease
por: Jonaitis, Erin M, et al.
Publicado: (2023)

Item-Level Story Recall Predictors of Amyloid-Beta in Late Middle-Aged Adults at Increased Risk for Alzheimer’s Disease
por: Mueller, Kimberly D., et al.
Publicado: (2022)

Crosswalk study on blood collection‐tube types for Alzheimer's disease biomarkers
por: Jonaitis, Erin M., et al.
Publicado: (2022)

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)

Amyloid accumulation in Down syndrome measured with amyloid load
por: Zammit, Matthew D., et al.
Publicado: (2020)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation
por: Lao, Patrick J., et al.
Publicado: (2018)

Measuring longitudinal cognition: Individual tests versus composites
por: Jonaitis, Erin M., et al.
Publicado: (2019)

Caregiver appraisals of lucid episodes in people with late‐stage Alzheimer's disease or related dementias
por: Griffin, Joan M., et al.
Publicado: (2022)

Cerebrospinal fluid ratios with Aβ(42) predict preclinical brain β-amyloid accumulation
por: Racine, Annie M., et al.
Publicado: (2015)

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum
por: Allison, Samantha L., et al.
Publicado: (2019)

COVID‐19 pandemic experiences of older adults with dementia in community and residential care settings: Results from a US national survey
por: Schrack, Jennifer A., et al.
Publicado: (2022)

Low cerebral blood flow is associated with lower memory function in metabolic syndrome
por: Birdsill, Alex C, et al.
Publicado: (2013)

Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults
por: Willette, Auriel A., et al.
Publicado: (2013)

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2023)

In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer’s disease
por: Levin, Fedor, et al.
Publicado: (2021)

Intracranial vascular flow oscillations in Alzheimer’s disease from 4D flow MRI
por: Rivera-Rivera, Leonardo A., et al.
Publicado: (2020)

Impact of sex and APOE ε4 on age-related cerebral perfusion trajectories in cognitively asymptomatic middle-aged and older adults: A longitudinal study
por: Wang, Rui, et al.
Publicado: (2021)

Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring
por: Ashton, Nicholas J., et al.
Publicado: (2022)

Cohort study of electroencephalography markers of amyloid-tau-neurodegeneration pathology
por: Tanabe, Sean, et al.
Publicado: (2020)

Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation
por: Racine, Annie M., et al.
Publicado: (2014)

The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions
por: Johnson, Sterling C., et al.
Publicado: (2017)

Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention
por: Doherty, Benjamin M., et al.
Publicado: (2015)

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
por: Merluzzi, Andrew P., et al.
Publicado: (2019)

Measurement batch differences and between‐batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values
por: Ma, Yue, et al.
Publicado: (2021)

Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease
por: Miners, James, et al.
Publicado: (2023)

Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis
por: Kim, Won Hwa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5s1o0spr03qampau2eu8an98jk